Fixes Book Closure for AGM (Cut-off date for e-voting)
Bafna Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2017 to September 30, 2017 (both days inclusive) for the purpose of 22nd Annual General Meeting (AGM) of the Company to be held on September 30, 2017. Outcome of Board Meeting
1. Approval of Directors report 2. Fixing of date, place, time of 22nd AGM. 3. Fixing of Book Closure for 22nd AGM 4. Fixing of Cut-off Date for voting 5. To recommend the appointment of Statutory Auditor of the Company. 6. To recommend the re-appointment of Managing Director of the Company 7.To recommend the re-appoint of Whole time Director of the Company. Financial Results For 30Th June, 2017.
Unaudited Financial Results for the quarter ended 30th June, 2017. Outcome of Board Meeting
Outcome of Meeting of Board of Directors held on 8th August, 2017. Board Meeting On 8Th August, 2017.
Meeting of the Board is scheduled on Tuesday, the 8th of August, 2017, to consider among other matters, financial results for quarter ended 30th June, 2017. Shareholding for the Period Ended June 30, 2017
Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended 30Th June, 2017.
Statement of Investor Complaints for the quarter ended 30th June, 2017, under Regulation 13(3) of SEBI (LODR) Regulations. Declaration Of Unmodified Opinion
Declaration of Unmodified Opinion on the Audited Standalone and Consolidated Financial Results for the year ended 31st March, 2017. Financial Results For The Year Ended 31St March, 2017
Standalone and Consolidated Financials for the quarter and year ended 31st March, 2017.